Tyvaso 0.6 refill kit
Ended Awarded
- Contract number
- 36C24525N0165
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,694
Award facts
- Contract value 100% obligated
- $14,693.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price delivery order awarded to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, under the U.S. Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The $14,693.62 order is for the TYVASO 0.6 REFILL KIT, a pulmonary arterial hypertension medication. United Therapeutics holds a $198 million FSS contract and a $50 million Blanket Purchase Agreement (BPA) with the VA, which facilitate the centralized procurement of its entire drug portfolio, including Tyvaso, Remodulin, Orenitram, and Unituxin, to support the VA's integrated healthcare networks. This delivery order does not have a set-aside designation. The ultimate completion date for this order is November 12, 2024.
Quick answers
Who was awarded contract 36C24525N0165?
36C24525N0165 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 7, 2024.
How much is contract 36C24525N0165 worth?
The government has obligated $14,694 on 36C24525N0165.
Is contract 36C24525N0165 an order under another contract?
Yes. 36C24525N0165 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0165 competed?
The extent of competition for 36C24525N0165 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award